EUVIMED · CrossrefZeitschrift
Diabetology & Metabolic Syndrome
ISSN 1758-5996 · Springer Science and Business Media LLC
Neueste Artikel
The paradox of high metabolic risk and low FIB-4 scores in the elderly: a nationwide community-based analysis (DAHUDER geriatric MASLD study)
Cerebrovascular outcomes of semaglutide in patients with type 2 diabetes mellitus or obesity: a systematic review and meta-analysis
Comparative efficacy and safety of stem cell-based therapies for diabetes mellitus: a systematic review and Bayesian network meta-analysis of randomized controlled trials
Risk-guided CKM care through a kidney lens: an architecture for translating risk into action
Optimizing obesity treatment in adolescent: a network meta-analysis and meta-regression of HIIT vs. other exercise modalities on cardiometabolic markers
Empagliflozin’s role in cardiometabolic disease treatment: an Egyptian expert’s view
Associations between glycolysis related metabolites and short-term mortality after ST-elevation myocardial infarction
Association of Type 2 diabetes remission with mortality and vascular outcomes: a systematic review and meta-analysis of longitudinal studies
Nonlinear and linear associations of body roundness index with all-cause and cardiovascular mortality in US adults with cardiovascular-kidney-metabolic syndrome
Effects of carbohydrate counting training versus standard nutritional and medical therapy on glycemic control and sarcopenia in type 2 diabetes: an open-label randomized controlled trial
Study on the pathogenic mechanisms and clinical treatment of advanced glycation end products (AGEs) in diabetic complications
Risk factors for metabolic syndrome: an umbrella review of systematic reviews and meta-analyses
Effects of continuous calorie restriction versus time-restricted intermittent fasting on glycemic variability in individuals with type 2 diabetes: a randomized crossover trial
Clinical potential of miR-519d-3p in diabetic kidney disease and its regulatory mechanism on podocyte injury through targeting STAT3
Association between glycemic variability and delirium in critically ill older adults patients: a retrospective cohort study
Association of hemoglobin glycation index with all-cause mortality in critically
Association of serum vitamin C and E levels with mortality in individuals with metabolic syndrome
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes with CKD stages 2–4: a target trial emulation
Retinal vessel calibers and metabolic syndrome in the UK Biobank: A cross-sectional study
The association between stress hyperglycemia ratio and adverse outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
Association of glucagon-like peptide-1 receptor agonist therapy with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
Early-onset gestational diabetes mellitus and secondary maternal and neonatal complications: A systematic review and meta-analysis
Comparative effects of glucagon-like peptide-1-based regimens on peripheral arterial and limb events in type 2 diabetes: a network meta-analysis of randomized trials
Development and validation of a First Trimester Clinical Risk Score (FTRS) for predicting gestational diabetes mellitus in a low-resource setting: an observational cohort study
Reported cardiovascular events and cardiometabolic risk markers with orforglipron and danuglipron in adults with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized trials
Endocrine and metabolic profiling of PMOS rat models in relation to clinical obese and non-obese phenotypes
Effects of synbiotic supplementation on clinical symptoms and metabolic outcomes in patients with painful diabetic neuropathy: a pilot randomized controlled trial
A low-calorie balanced diet improves hepatic steatosis and preserves skeletal muscle in obesity: evidence from clinical and experimental studies
Determinants of MASLD and liver fibrosis in maintenance hemodialysis: a prospective evaluation of metabolic, nutritional, and volume-related factors
Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal
EUVIMED